Publications Database

Alaghband-Rad J. et al. (2013)

Memantine induced speech problem in two patients with autistic disorder.

Daru

21(1), pp. 54

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2017)

Safety and efficacy of memantine in children with autism: Randomized, placebo-controlled study and open-label extension.

Journal of Child and Adolescent Psychopharmacology

June, 27(5), pp. 403-412.

Read Abstract (New Window) Read Full (New Window)

Aman M. G. , Hollway J. A. , Arnold L. E. (2008)

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 713-738

Read Abstract (New Window)

Chez M. G. et al. (2007)

Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability.

Journal of Child Neurology

22(5), pp. 574-579

Read Abstract (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Dialogues in Clinical Neuroscience

14(3), pp. 263-279.

Read Abstract (New Window) Read Full (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert Opinion on Pharmacotherapy

13(11), pp. 1615-1629.

Read Abstract (New Window)

Erickson C. A. et al. (2007)

A retrospective study of memantine in children and adolescents with pervasive developmental disorders.

Psychopharmacology (Berl)

191(1), pp. 141-147

Read Abstract (New Window)

Erickson C. A. , Chambers J. (2006)

Memantine for disruptive behavior in autistic disorder.

Journal of Clinical Psychiatry

67(6), pp. 1000

Erickson C. A. , Mullett J. E. , McDougle C. J. (2009)

Open-label memantine in fragile X syndrome.

Journal of Autism and Developmental Disorders

39(12), pp. 1629-1635.

Read Abstract (New Window)

Gürkana C. K. , Hagerman R. J. (2012)

Targeted treatments in autism and fragile X syndrome.

Research in Autism Spectrum Disorders

6(4), pp. 1311-1320.

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

International Journal of Neuropsycholpharmacology

16(4), pp. 783-789.

Read Abstract (New Window)

Hendren. R. L. (2013)

Autism: biomedical complementary treatment approaches.

Child and Adolescent Psychiatric Clinics of North America

22(3), pp. 443-456.

Read Abstract (New Window)

Joshi G. et al. (2016)

A prospective open-label trial of memantine hydrochloride for the treatment of social deficits in intellectually capable adults with autism spectrum disorder.

Journal of Psychopharmacology

June, 36(3), pp. 262-271.

Read Abstract (New Window)

Niederhofer H. (2007)

Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism.

Journal of Clinical Psychopharmacology

27(3), pp. 317-318

Nikvarz N. N. et al. (2017)

Comparing efficacy and side effects of memantine vs. risperidone in the treatment of autistic disorder.

Pharmacopsychiatry

January, 50(1), pp. 19-25.

Read Abstract (New Window)

Owley T. et al. (2006)

A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 517-552

Read Abstract (New Window)

Parr J. R. (2008)

Autism.

Clinical Evidence (Online)

pii: 0322

Read Abstract (New Window)

American Society of Health-System Pharmacists (2011)

Memantine.

Bethesda, MD: U.S. National Library of Medicine

Read Full (New Window)

Posey D. J. , Erickson C. A. , McDougle C. J. (2008)

Developing drugs for core social and communication impairment in autism.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 787-801

Read Abstract (New Window) Read Full (New Window)

Rossignol D. A. , Frye R. E. (2014)

The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review.

Frontier in Pediatrics

August, 2

Read Abstract (New Window) Read Full (New Window)